Lubbers Ellen R, Mohler Peter J
Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United States; Department of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, United States; Department of Physiology & Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States; Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
J Mol Cell Cardiol. 2016 Dec;101:127-133. doi: 10.1016/j.yjmcc.2016.11.003. Epub 2016 Nov 8.
Reversible protein phosphorylation is central to a variety of cardiac processes including excitation-contraction coupling, Ca handling, cell metabolism, myofilament regulation, and cell-cell communication. While kinase pathways linked with elevated adrenergic signaling have been a major focus for the cardiovascular field over the past half century, new findings support the critical role of protein phosphatases in both health and disease. Protein phosphatase 2A (PP2A) is a central cardiac phosphatase that regulates diverse myocyte functions through a host of target molecules. Notably, multiple mechanisms have evolved to dynamically tune PP2A function, including modulation of the composition, phosphorylation, methylation, and localization of PP2A holoenzyme populations. Further, aberrations in this regulation of PP2A function may contribute to cardiac pathophysiology. In summary, PP2A is a critical regulatory molecule in both health and disease, with a myriad of targets in heart. Based on their unique structure, localization, and regulatory properties, PP2A subunits represent exciting therapeutic targets to modulate altered adrenergic signaling in cardiovascular disease.
可逆性蛋白质磷酸化是多种心脏过程的核心,包括兴奋 - 收缩偶联、钙处理、细胞代谢、肌丝调节和细胞间通讯。在过去的半个世纪里,与肾上腺素能信号升高相关的激酶途径一直是心血管领域的主要研究重点,但新的研究结果支持了蛋白磷酸酶在健康和疾病中的关键作用。蛋白磷酸酶2A(PP2A)是一种核心的心脏磷酸酶,它通过一系列靶分子调节多种心肌细胞功能。值得注意的是,已经进化出多种机制来动态调节PP2A的功能,包括对PP2A全酶群体的组成、磷酸化、甲基化和定位的调节。此外,PP2A功能调节的异常可能导致心脏病理生理学的发生。总之,PP2A在健康和疾病中都是一种关键的调节分子,在心脏中有众多靶标。基于其独特的结构、定位和调节特性,PP2A亚基是调节心血管疾病中肾上腺素能信号改变的令人兴奋的治疗靶点。